Results 91 to 100 of about 25,337,422 (423)

Proteomics in cancer research

open access: yesInternational Journal of Gynecological Cancer, 2002
With the human genome sequence now determined, the field of molecular medicine is moving beyond genomics to proteomics. In the field of cancer research, the key question is: how can oncologists best use techniques of proteomics in basic research and clinical application?
John J. Kavanagh, Wei Hu, W. Wu
openaire   +3 more sources

Further Guidance in Implementing the Standardized 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Score

open access: yesCancer Epidemiology, Biomarkers and Prevention, 2020
The 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Score was developed to establish a simple, standardized scoring system for researchers to quantify adherence to the 2018 WCRF/AICR Cancer Prevention Recommendations ...
Marissa M. Shams-White   +5 more
semanticscholar   +1 more source

Characteristics of the Kelch domain containing (KLHDC) subfamily and relationships with diseases

open access: yesFEBS Letters, EarlyView.
The Kelch protein superfamily includes 63 members, with the KLHDC subfamily having 10 proteins. While their functions are not fully understood, recent advances in KLHDC2's structure and role in protein degradation have highlighted its potential for drug development, especially in PROTAC therapies.
Courtney Pilcher   +6 more
wiley   +1 more source

Update on pathology laboratory development and research in advancing regional cancer care in Malawi

open access: yesFrontiers in Medicine
The pathology laboratory at Kamuzu Central Hospital (KCH) in Lilongwe, Malawi was established in 2011. We published our initial experiences in laboratory development and telepathology in 2013 and 2016, respectively.
Amy J. Brownlee   +25 more
doaj   +1 more source

Humphrey Center News: Fall 1988 v. 3, no. 2 [PDF]

open access: yes, 1988
Newsletter of the Hubert H.
Hubert H. Humphrey Cancer Research Center of Boston University   +1 more
core  

Cancer For Researchers

open access: yes, 2022
All information about Cancer for researchers. Cancer biology (cellular and molecular, Genetics, Epigenetics, Metastasis, Metabolism), Causes (Chemicals, Diet and exercise, Infection, Radiation, Heredity, Physical agents, Hormones, Autoimmune diseases), Classification(Carcinoma, Sarcoma, Blastoma, Lymphoma, and leukemia), Treatment (Chemotherapy ...
Aliasghar Tabatabaei mohammadi   +6 more
openaire   +2 more sources

Distinct dysregulated pathways in sporadic and Lynch syndrome‐associated colorectal cancer offer insights for targeted treatment

open access: yesFEBS Letters, EarlyView.
This study explores the distinct molecular mechanisms underlying Lynch syndrome‐associated and sporadic colorectal cancer (CRC). By highlighting the therapeutic potential of targeting the PI3K‐Akt pathway in Lynch syndrome‐associated CRC and the Wnt pathway in sporadic CRC, the findings open avenues for personalised treatment strategies, aiming to ...
May J. Krause   +2 more
wiley   +1 more source

Non-Fungible Tokens for Organoids: Decentralized Biobanking to Empower Patients in Biospecimen Research

open access: yesBlockchain in Healthcare Today
Introduction: Scientists use donated biospecimens to create organoids, miniature copies of patient tumors1 that are revolutionizing precision medicine2 and drug discovery.
William Sanchez   +4 more
doaj   +1 more source

Cancer Research in 2021 [PDF]

open access: yesCancer Cell, 2021
Cancer research has been severely impacted by COVID-19. What does the future of cancer research look like in the new year after the pandemic?
openaire   +2 more sources

Immunoregulatory mechanisms of the arachidonic acid pathway in cancer

open access: yesFEBS Letters, EarlyView.
The central role of the arachidonic acid (AA) pathway in anticancer immunity. Enzymes and metabolites of the AA pathway can play both immunosuppressive and immunostimulatory roles in the tumor microenvironment. Therefore, their tailored targeting could be beneficial as a standalone therapy or in combination with current cancer immunotherapy.
Maria Tredicine   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy